Serology-based therapeutic strategy in SARS-CoV-2-infected patients

•Patients with negative serology against COVID19 due receive convalescent plasma treatment.•Patients with positive serology against COVID19 due avoid convalescent plasma treatment.•High-dose dexamethasone is necessary in patients with positive serology against COVID19.•Serology-based therapeutic str...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International immunopharmacology 2021-12, Vol.101 (Pt B), p.108214-108214, Article 108214
Hauptverfasser:	Garcia-Muñoz, Ricardo, Farfán-Quiroga, Giovanna, Ruiz-de-Lobera, Noemí, Feliu, Jesus, Anton-Remirez, Judith, Nájera Irazu, Maria José, Lisa Catón, Valentín, Oteo-Revuelta, José Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anti-Inflammatory Agents - therapeutic use Antibodies Antibodies, Viral - blood B-Lymphocytes - immunology COVID-19 COVID-19 - blood COVID-19 - immunology COVID-19 - therapy COVID-19 Drug Treatment COVID-19 Serotherapy Depletion Dexamethasone Dexamethasone - therapeutic use Female Glucocorticoids - therapeutic use Humans Immunization, Passive Immunoglobulin G - blood Immunoglobulin M - blood Immunology Immunotherapy Impact analysis Infections Inflammation Killer Cells, Natural - immunology Life Sciences & Biomedicine Lymphocyte Lymphocytes Lymphocytes B Lymphocytes T Male Middle Aged Patients Pharmacology & Pharmacy Plasma Recovery Retrospective Studies SARS-CoV-2 SARS-CoV-2 - immunology Science & Technology Serology Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 T-Lymphocytes - immunology Therapy Tocilizumab Viral diseases Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!